NovoCure Ltd

NASDAQ:NVCR  
75.62
+0.74 (+0.99%)
Earnings Announcements

Novocure Reports Qtrly Net Revenues Of $140.9 Mln

Published: 07/28/2022 11:43 GMT
NovoCure Ltd (NVCR) - Quarterly Net Revenues of $140.9 Million, a 6% Increase Year-over-year.
Top-line Data From Lunar Pivotal Study Will Be Distributed in Early Q1 2023 Versus Final Week of 2022.
Qtrly Diluted Net Loss per Ordinary Share $0.23.
Q2 Earnings per Share View $-0.15, Revenue View $135.0 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $131.95 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $134.9 Million
Next Quarter EPS Guidance is expected to be -$0.28

More details on our Analysts Page.